Xinjiang Zhongtai Chemical Co., Ltd. (SHE:002092)
China · Delayed Price · Currency is CNY 6.28
-0.43 (-6.41%)
May 7, 2026, 3:04 PM CST
SHE:002092 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 28,526 | 28,015 | 29,178 | 36,334 | 50,960 | 62,096 |
Other Revenue | 681.31 | 681.31 | 945.11 | 783.67 | 702.16 | 797.77 |
| 29,207 | 28,696 | 30,123 | 37,118 | 51,662 | 62,893 | |
Revenue Growth (YoY) | 0.33% | -4.74% | -18.84% | -28.15% | -17.86% | -25.32% |
Cost of Revenue | 24,146 | 23,347 | 25,464 | 34,033 | 44,917 | 54,157 |
Gross Profit | 5,061 | 5,349 | 4,660 | 3,085 | 6,745 | 8,736 |
Selling, General & Admin | 2,980 | 3,103 | 3,237 | 3,417 | 3,628 | 3,219 |
Research & Development | 526.74 | 531.76 | 377.4 | 261.37 | 444.03 | 76.65 |
Other Operating Expenses | 569.6 | 567.18 | 473.73 | 394.41 | 527.7 | 430.24 |
Operating Expenses | 4,023 | 4,148 | 4,083 | 4,269 | 4,627 | 3,835 |
Operating Income | 1,038 | 1,201 | 576.42 | -1,184 | 2,119 | 4,901 |
Interest Expense | -1,040 | -1,040 | -1,027 | -1,176 | -1,155 | -1,296 |
Interest & Investment Income | 95.97 | 95.97 | 48.4 | 124.34 | 461.14 | 156.99 |
Currency Exchange Gain (Loss) | 8.5 | 8.5 | -6.87 | -24.75 | 56.09 | -14.07 |
Other Non Operating Income (Expenses) | -157.06 | -148.89 | -31.55 | -183.93 | -85.8 | -80.36 |
EBT Excluding Unusual Items | -55.27 | 116.65 | -440.25 | -2,445 | 1,395 | 3,667 |
Impairment of Goodwill | - | - | -0.29 | -57.03 | - | - |
Gain (Loss) on Sale of Investments | -189.99 | -231.65 | -295.8 | -485.04 | -4.62 | 19.57 |
Gain (Loss) on Sale of Assets | 12.7 | 3.83 | 3.25 | 3.84 | 6.28 | 6.24 |
Asset Writedown | -52.87 | -110.26 | -404.26 | -287.11 | -1.23 | -114.48 |
Other Unusual Items | 101.14 | 101.14 | 11.99 | 49.03 | 14.95 | 67.7 |
Pretax Income | -184.3 | -120.29 | -1,125 | -3,221 | 1,411 | 3,646 |
Income Tax Expense | 196.3 | 198.8 | 157.79 | -35.41 | 251.72 | 572.98 |
Earnings From Continuing Operations | -380.6 | -319.09 | -1,283 | -3,186 | 1,159 | 3,073 |
Minority Interest in Earnings | 39.03 | 30.34 | 306.64 | 320.47 | -382.77 | -325.49 |
Net Income | -341.57 | -288.75 | -976.52 | -2,865 | 776.28 | 2,748 |
Net Income to Common | -341.57 | -288.75 | -976.52 | -2,865 | 776.28 | 2,748 |
Net Income Growth | - | - | - | - | -71.75% | 1801.27% |
Shares Outstanding (Basic) | 2,576 | 2,576 | 2,576 | 2,576 | 2,576 | 2,325 |
Shares Outstanding (Diluted) | 2,576 | 2,576 | 2,576 | 2,576 | 2,576 | 2,325 |
Shares Change (YoY) | 0.05% | -0.00% | 0.00% | 0.01% | 10.76% | 8.28% |
EPS (Basic) | -0.13 | -0.11 | -0.38 | -1.11 | 0.30 | 1.18 |
EPS (Diluted) | -0.13 | -0.11 | -0.38 | -1.11 | 0.30 | 1.18 |
EPS Growth | - | - | - | - | -74.49% | 1655.87% |
Free Cash Flow | 501.44 | 272.21 | 2,945 | -105.01 | 27.52 | 2,808 |
Free Cash Flow Per Share | 0.20 | 0.11 | 1.14 | -0.04 | 0.01 | 1.21 |
Dividend Per Share | - | - | - | - | 0.100 | 0.120 |
Dividend Growth | - | - | - | - | -16.67% | 1100.00% |
Gross Margin | 17.33% | 18.64% | 15.47% | 8.31% | 13.06% | 13.89% |
Operating Margin | 3.55% | 4.19% | 1.91% | -3.19% | 4.10% | 7.79% |
Profit Margin | -1.17% | -1.01% | -3.24% | -7.72% | 1.50% | 4.37% |
Free Cash Flow Margin | 1.72% | 0.95% | 9.78% | -0.28% | 0.05% | 4.46% |
EBITDA | 4,592 | 4,665 | 3,679 | 1,447 | 4,580 | 7,182 |
EBITDA Margin | 15.72% | 16.26% | 12.21% | 3.90% | 8.87% | 11.42% |
D&A For EBITDA | 3,554 | 3,464 | 3,102 | 2,631 | 2,461 | 2,281 |
EBIT | 1,038 | 1,201 | 576.42 | -1,184 | 2,119 | 4,901 |
EBIT Margin | 3.55% | 4.19% | 1.91% | -3.19% | 4.10% | 7.79% |
Effective Tax Rate | - | - | - | - | 17.84% | 15.71% |
Revenue as Reported | 28,696 | 28,696 | 30,123 | 37,118 | 51,662 | 62,893 |
Advertising Expenses | - | 17.73 | 6.68 | - | - | - |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.